Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus InfectionPaul M. Scola, Fiona McPhee, Sing‐Yuen Sit et al.|Journal of Medicinal Chemistry|2014Cited by 69
Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS-650032), a Potent Hepatitis C Virus NS3 Protease InhibitorKathleen Mosure, Michael Sinz, Jay O. Knipe et al.|Journal of Pharmaceutical Sciences|2015Cited by 32
Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical StudiesKap‐Sun Yeung, John F. Kadow, Brett R. Beno et al.|Journal of Medicinal Chemistry|2017Cited by 31
CCDC 984481: Experimental Crystal Structure DeterminationPaul M. Scola, Fiona McPhee, Alan Xiangdong Wang et al.|The Cambridge Structural Database|2014Cited by 0
CCDC 1541557: Experimental Crystal Structure DeterminationKap‐Sun Yeung, John F. Kadow, Brett R. Beno et al.|The Cambridge Structural Database|2017Cited by 0